Global Artificial Intelligence Ai In Precision Medicine Market Opportunities 2024, Forecast To 2033
8 Mar, 2024
The artificial intelligence (AI) in precision medicine market is set to expand from $1.82 billion in 2023 to $2.37 billion in 2024, with a 30.2% CAGR. The forecast anticipates exponential growth, reaching $6.86 billion by 2028, driven by precision medicine initiatives and increased demand for predictive analytics, with major trends including AI-driven biomarker discovery and enhanced patient stratification.
Global Artificial Intelligence AI in Precision Medicine Market Key Driver
The artificial intelligence in precision medicine market is expected to expand due to the high prevalence of chronic illnesses and respiratory disorders. The United Nations predicts that chronic diseases will account for 86% of global deaths by 2050, highlighting the need for AI-driven precision medicine solutions.
Get A Free Sample Of The Global Artificial Intelligence AI in Precision Medicine Market ReportGlobal Artificial Intelligence AI in Precision Medicine Market Segments
The artificial intelligence (ai) in precision medicine market covered in this report is segmented –
1) Component:Hardware, Software, Service
2) Technology:Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing
3) Therapeutic Application:Oncology, Cardiology, Neurology, Respiratory, Other Therapeutic Applications
By Geography: The countries covered in the artificial intelligence (ai) in precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the artificial intelligence (AI) in precision medicine market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Artificial Intelligence AI in Precision Medicine Industry Players
Alphabet Inc.; Microsoft Corporation; Intel Corporation; International Business Machines Corporation; AstraZeneca PLC; Sanofi S.A.; NVIDIA Corporation; GE HealthCare Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Helix Inc.; Sema4 Holdings Corp.; SOPHiA GENETICS SA; Insilico Medicine; BenevolentAI Limited; Fabric Genomics Inc.; Tempus Technologies Inc.; Enlitic Inc.; PathAI Inc.; Genuity Science Inc.; BERG LLC; Perthera Inc.; Vuno Inc.; CureMetrix Inc.; AITIA International Inc.; Zephyr AI; Freenome Inc.; PetaGene Ltd.; Suki AI Inc.; BioXcel Therapeutics Inc.
Get The Full Global Artificial Intelligence AI in Precision Medicine Market Report
Artificial Intelligence AI in Precision Medicine Market Overview
Artificial intelligence in precision medicine refers to leveraging sophisticated computation and inference to generate insights, enabling the system to reason and learn and helping healthcare professionals make decisions through augmented intelligence. Artificial intelligence in precision medicine is used to optimize diagnosis, therapeutic intervention, and prognosis in healthcare.